Breaking News Instant updates and real-time market news.

FIVE

Five Below

$39.88

0.52 (1.32%)

, ULTA

Ulta Beauty

$257.41

-2.09 (-0.81%)

18:31
12/01/16
12/01
18:31
12/01/16
18:31

On The Fly: After Hours Movers

UP AFTER EARNINGS: Five Below (FIVE), up 10.8%... Ulta Beauty (ULTA), up 6.2%... Ascena Retail (ASNA), up 3.8%. DOWN AFTER EARNINGS: Workday (WDAY), down 11.9%... G-III Apparel (GIII), down 7.9%... Ambarella (AMBA), down 7.2%... Smith & Wesson (SWHC), down 6.7%... Zumiez (ZUMZ), down 5.3%. ALSO LOWER: Intersections (INTX), down 7% after it approved the closure of its Voyce pet health monitoring business... SM Energy (SM), down 3.6% after it filed to sell 8M shares of common stock... Starbucks (SBUX), down 3.4% after chief operating officer Kevin Johnson was named to succeed Howard Schultz as chief executive officer... Allegheny Technologies (ATI), down 3.4% after it suspended its quarterly dividend... Gap (GPS), down 1.2% after it said that November comparable store sales fell 1% year-over-year.

FIVE

Five Below

$39.88

0.52 (1.32%)

ULTA

Ulta Beauty

$257.41

-2.09 (-0.81%)

ASNA

Ascena Retail

$5.83

-0.21 (-3.48%)

WDAY

Workday

$81.60

-2.72 (-3.23%)

GIII

G-III Apparel

$26.88

-0.28 (-1.03%)

AMBA

Ambarella

$61.39

-0.13 (-0.21%)

SWHC

Smith & Wesson

$23.98

0.65 (2.79%)

ZUMZ

Zumiez

$24.55

-0.25 (-1.01%)

INTX

Intersections

$2.15

-0.1 (-4.44%)

SM

SM Energy

$40.17

0.31 (0.78%)

SBUX

Starbucks

$58.51

0.54 (0.93%)

ATI

Allegheny Technologies

$17.76

0.22 (1.25%)

GPS

Gap

$25.05

0.08 (0.32%)

  • 01

    Dec

  • 01

    Dec

  • 01

    Dec

  • 01

    Dec

  • 01

    Dec

  • 01

    Dec

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 08

    Dec

  • 08

    Dec

  • 13

    Dec

  • 13

    Dec

  • 14

    Dec

  • 09

    Jan

  • 09

    Jan

  • 02

    Dec

FIVE Five Below
$39.88

0.52 (1.32%)

10/20/16
MKMP
10/20/16
NO CHANGE
MKMP
Five Below weakness creates buying opportunity, says MKM Partners
Noting that Five Below has tumbled 29% since July, MKM analyst Patrick McKeever attributes the weakness to several factors, including the decline of the Pokemon Go craze and speculation about a drop in credit card transactions last quarter. The analyst says that little has changed about the company since July, and he says that the stock's valuation is low by historic standards. He keeps a $60 price target and Buy rating on the shares.
10/26/16
LBOW
10/26/16
INITIATION
Target $45
LBOW
Buy
Five Below initiated with a Buy at Longbow
Longbow analyst Mark Rupe initiated Five Below with a Buy and a $45 price target.
10/13/16
10/13/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Aaron's (AAN) initiated with a Buy at Jefferies. 2. eBay (EBAY) and Etsy (ETSY) coverage assumed with a Neutral at Wedbush. 3. Five Below (FIVE) and Dollar Tree (DLTR) were initiated with an Overweight at KeyBanc while the firm initiated Dollar General (DG) with a Sector Weight. 4. Baxter (BAX) initiated with an Outperform at Wells Fargo. 5. Symantec (SYMC) initiated with an Outperform at FBN Securities. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/26/16
10/26/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Mylan (MYL) initiated with a Buy at Mizuho. 2. Five Below (FIVE) initiated with a Buy at Longbow. 3. NetSuite (N) reinstated with an Underperform at BofA/Merrill. 4. Adient (ADNT) initiated with a Buy at Northcoast. 5. Party City (PRTY) initiated with a Neutral at Goldman. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
ULTA Ulta Beauty
$257.41

-2.09 (-0.81%)

10/11/16
BARD
10/11/16
NO CHANGE
Target $305
BARD
Outperform
Ulta Beauty risk/reward attractive ahead of investor day, says Baird
Baird analyst Mark Altschwager previewed Ulta Beauty's investor day and said the recent pullback in the shares has lead to an attractive risk/reward for investors. The analyst expects management's tone to be upbeat, for them to update progress on long term goals, and for them to clarify revenue/unit potential, margin drivers, and supply chain initiatives. Altschwager reiterated his Outperform rating and $305 price target on Ulta Beauty shares.
10/14/16
BARD
10/14/16
NO CHANGE
Target $305
BARD
Outperform
Ulta Beauty investor day reinforces long-term growth opportunity, says Baird
Baird analyst Mark Altschwager said the Ulta Beauty analyst day was upbeat and the company raised its guidance and outlined a larger total addressable market opportunity. The analyst said the company offers the rare combination of category growth, defensive moats, unit whitespace, and exceptional management. Altschwager reiterated his Outperform rating and $305 price target on Ulta Beauty shares.
11/10/16
OPCO
11/10/16
NO CHANGE
Target $300
OPCO
Outperform
Oppenheimer sees Ulta Beauty recent pullback as 'attractive entry point'
Oppenheimer analyst Rupesh Parikh notes that Ulta Beauty's shares are down 11% since the day following its analyst day and guidance raise. The analyst says shares are again close to a bottom, and views the recent pullback as an attractive entry point. The health of the beauty category remains "very solid," Ulta Beauty's competitive position is only strengthening, and the chain is very well positioned this holiday season to capture more than its fair share of the category spend, Parikh says. He reiterates an Outperform rating and $300 price target on the shares.
11/30/16
MSCN
11/30/16
NO CHANGE
MSCN
Ulta Beauty Q3 comps stores sales below guidance, says MScience
ASNA Ascena Retail
$5.83

-0.21 (-3.48%)

09/20/16
09/20/16
DOWNGRADE

Perform
Ascena Retail downgraded to Perform at Oppenheimer
As previously reported, Oppenheimer analyst Anna Andreeva downgraded Ascena Retail to Perform from Outperform following the company's "disappointing" Q4 EPS miss. The analyst says that while Justice's turnaround is proceeding on plan, volatility across other divisions keeps her sidelined.
09/20/16
RBCM
09/20/16
DOWNGRADE
RBCM
Sector Perform
Ascena Retail downgraded on Q4 results at RBC Capital
As noted earlier, RBC Capital downgraded Ascena to Sector Perform from Outperform. Analyst Brian Tunick downgraded the stock based on the company's Q4 EPS miss and its lower than expected fiscal 2017 EPS guidance. Target $7.
09/20/16
RHCO
09/20/16
NO CHANGE
RHCO
Ascena Retail outlook still positive despite Q4 miss, says SunTrust
SunTrust analyst Pamela Quintiliano says that Ascena's initiatives remain on track, as the momentum of its Justice unit should continue during the holiday season. She thinks that the company has multiple additional near-term positive catalysts. The analyst cut her price target on the shares to $8 from $10 but keeps a Buy rating on the stock.
09/20/16
09/20/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Ford (F) downgraded to Neutral from Buy at Buckingham with analyst Joseph Amaturo saying he believes North American volume and pricing trends for trucks will deteriorate and is concerned that the passenger car market will remain challenged given stiff competition from Japanese and European OEMs that can heavily discount due to weak currencies. 2. General Mills (GIS) downgraded to Underperform from Neutral at Consumer Edge. 3. Ascena Retail (ASNA) downgraded to Sector Perform from Outperform at RBC Capital and to Perform from Outperform at Oppenheimer. 4. Avnet (AVT) downgraded to Hold from Buy at Stifel and to Sell from Hold at Cross Research. 5. HD Supply (HDS) downgraded to Sector Perform from Outperform at RBC Capital with analyst Deane Dray saying it will take several quarters for the company to address its supply chain errors, and she expects the stock "to stay range bound over the medium term." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
WDAY Workday
$81.60

-2.72 (-3.23%)

10/18/16
PIPR
10/18/16
NO CHANGE
Target $90
PIPR
Overweight
Piper sees ServiceNow Q3 earnings report as catalyst
Piper Jaffray analyst Alex Zukin says his recent conversations with industry partners indicate "strong" renewal and net new business in ServiceNow's (NOW) Q3. He expects the company to outperform consensus expectations. Zukin sees the earnings report as a catalyst and points out that shares of ServiceNow are down 12% year-to-date while trading at a 14% discount to Workday (WDAY). The analyst reiterates an Overweight rating on ServiceNow with a $90 price target.
09/30/16
OPCO
09/30/16
NO CHANGE
Target $100
OPCO
Outperform
Workday price target raised to $100 from $90 at Oppenheimer
Oppenheimer analyst Brian Schwartz raised his price target for Workday to $100 saying his customer survey makes him "increasingly comfortable" with the company's current business momentum. The analyst is "optimistic "about bookings and growth trends and sees low risk to estimates. Schwartz continues to view Workday as top 2016 pick with an Outperform rating.
10/03/16
ADAM
10/03/16
NO CHANGE
Target $110
ADAM
Buy
Workday price target raised to $110 from $98 at Canaccord
Canaccord analyst Richard Davis raised his price target on Workday to $110 from $98 as the company has grown into its current valuation and the stock will continue to advance on a sustainable basis in a bullish environment. Davis reiterated his Buy rating on Workday shares.
09/28/16
09/28/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Workday (WDAY) upgraded to Neutral from Underperform at Wedbush with analyst Steve Koenig citing second-half 2016 sales potential, following a first-half which he thinks wasn't as good as generally perceived. 2. Dillard's (DDS) upgraded to Outperform from Neutral at Credit Suisse with analyst Michael Exstein citing the company's consistency in capital allocation and its valuation, which he says is at the low end of its historic trading range. 3. Cypress Energy (CELP) upgraded to Buy from Hold at Stifel analyst Michael Hoffman saying the CEO is upbeat on the company's outlook and its ability to maintain its distribution at current levels. 4. Huntington Bancshares (HBAN) upgraded to Buy from Hold at Deutsche Bank with analyst Matt O'Connor saying the 15% pullback in the shares since the FirstMerit (FMER) deal was announced is overdone. 5. Hi-Crush Partners (HCLP) upgraded to Neutral from Sell at UBS with analyst Shneur Gershuni saying recent commentary from oil field service companies indicate an increase in sand demand and intensity. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
GIII G-III Apparel
$26.88

-0.28 (-1.03%)

11/08/16
STFL
11/08/16
UPGRADE
STFL
Hold
G-III Apparel upgraded to Hold from Sell at Stifel
Stifel analyst Jim Duffy upgraded G-III to Hold citing balanced risk/reward.
09/28/16
LYON
09/28/16
INITIATION
LYON
Outperform
G-III Apparel initiated with an Outperform at CLSA
CLSA analyst Rick Patel initiated G-III Apparel with an Outperform rating and a $34 price target.
10/04/16
STPT
10/04/16
UPGRADE
STPT
Buy
G-III Apparel upgraded to Buy from Hold at Standpoint Research
08/31/16
08/31/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Under Armour (UA) downgraded to Hold from Buy at Argus by John Staszak, based on his belief that the company will have to make significant investments to expand its business going forward. 2. First Solar (FSLR) downgraded to Hold from Buy at Argus by analysts Stephen Biggar and Jasper Hellweg, citing what they see as the company's lack of earnings visibility. The analysts say that the company's backlog is falling, while it is encountering "intense price competition." 3. Palo Alto Networks (PANW) downgraded to Outperform from Strong Buy at Raymond James by analyst Michael Turits, citing the company's weaker than expected guidance for FY17. Palo guided product growth to 12%-13%, nearly halfway below the consensus estimate of 22%, said Turits, who lowered his price target for the shares to $165 from $180. 4. G-III Apparel (GIII) downgraded to Sell from Hold at Stifel. Despite the recent decline in the stock, its risk/reward ratio is unfavorable given the multiple risks faced by the company, according to Stifel analyst Jim Duffy. 5. Quest Diagnostics (DGX) downgraded to Neutral from Buy at Mizuho. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
AMBA Ambarella
$61.39

-0.13 (-0.21%)

09/28/16
ROTH
09/28/16
INITIATION
Target $80
ROTH
Buy
Ambarella initiated with a Buy at Roth Capital
Roth Capital analyst Suji Desilva initiated Ambarella with a Buy rating and an $80 price target.
11/04/16
ADAM
11/04/16
NO CHANGE
Target $87
ADAM
Buy
Ambarella weakness a buying opportunity, says Canaccord
Canaccord analyst Matthew Ramsay noted Ambarella (AMBA) shares moved lower following a disappointing holiday sales outlook from GoPro (GPRO), but said the weakness is a buying opportunity. Ramsay reiterated his Buy rating and $87 price target on Ambarella shares, saying that the company's road map is being driven by the automotive industry, professional drones, and enterprise security cameras more than consumer action cameras.
09/02/16
PACS
09/02/16
NO CHANGE
PACS
Ambarella outlook remains positive, says Pacific Crest
After Ambarella reported better than expected results but maintained its flat to down 5% fiscal 2017 revenue guidance, Pacific crest analyst Brad Erickson says that the company's "outlook for drone sell-in was a bit disappointing." However, the analyst thinks that the company continues to display "rock solid execution" and can still beat expectations during the upcoming holiday season. The analyst keeps a $75 price target and Overweight rating on the shares.
10/12/16
ADAM
10/12/16
NO CHANGE
Target $87
ADAM
Buy
Ambarella leading technology position remains intact, says Canaccord
Canaccord analyst Matthew Ramsay said Ambarella's leading technology position remains intact. He noted the company has several growing end markets - including wearables, security, automotive and drone cameras - and believes long-term investors will be rewarded with the new design ramp. Ramsay reiterated his Buy rating and raised his price target to $87 from $86 on Ambarella shares.
SWHC Smith & Wesson
$23.98

0.65 (2.79%)

10/06/16
WDLK
10/06/16
DOWNGRADE
Target $29
WDLK
Hold
Smith & Wesson downgraded to Hold from Buy at Wunderlich
Wunderlich analyst Rommel Dionisio downgraded Smith & Wesson to Hold and lowered his price target for the shares to $29 from $36 citing decelerating industry demand.
11/21/16
LSCM
11/21/16
DOWNGRADE
LSCM
Hold
Smith & Wesson downgraded to Hold from Buy at Lake Street
11/21/16
LSCM
11/21/16
DOWNGRADE
Target $20
LSCM
Hold
Smith & Wesson downgraded on firearm uncertainty at Lake Street
Lake Street analyst Christopher Krueger downgraded Smith & Wesson to Hold from Buy and lowered his price target for the shares to $20 from $37. The analyst sees increased uncertainty for firearm sales. Shares the gun maker are off their highs but remain up 10c to $24.23 in afternoon trading.
09/26/16
COWN
09/26/16
NO CHANGE
Target $34
COWN
Outperform
Smith & Wesson potential selection by Army not included in guidance, says Cowen
Cowen analyst Cai von Rumohr said it was surprising that Smith & Wesson was not selected by the Army to compete in the testing phase of the Modular Handgun System, or MHS, project, but also noted that MHS was not included in the company's guidance. The analyst, who thinks S&W shares still look cheap, keeps an Outperform rating on the gunmaker's stock, which is down over 4% to $26.40 in pre-market trading.
ZUMZ Zumiez
$24.55

-0.25 (-1.01%)

10/13/16
PIPR
10/13/16
UPGRADE
PIPR
Overweight
Zumiez upgraded to Overweight from Neutral at Piper Jaffray
10/13/16
PIPR
10/13/16
UPGRADE
Target $44
PIPR
Overweight
Under Armour upgraded to Overweight after teen survey at Piper Jaffray
As previously reported, Piper Jaffray analyst Erinn Murphy upgraded Under Armour (UA) to Overweight from Neutral following the firm's semi-annual proprietary "Taking Stock With Teens" survey. The survey findings support on-going traction for Under Armour within footwear and the women's segment, noted Murphy, who raised her price target on the stock to $44 from $40. Based on the survey's results, other analysts at the firm also downgraded Estee Lauder (EL) to Neutral from Overweight and upgraded Zumiez (ZUMZ) to Overweight from Neutral.
11/04/16
WOLF
11/04/16
UPGRADE
WOLF
Peer Perform
Zumiez upgraded to Peer Perform from Underperform at Wolfe Research
Wolfe Research upgraded Zumiez to Peer Perform as comps have turned positive, promotions are down, and inventory reduced.
10/13/16
PIPR
10/13/16
UPGRADE
Target $28
PIPR
Overweight
Zumiez upgraded to Overweight after teen survey at Piper Jaffray
As previously reported, Piper Jaffray analyst Neely Tamminga upgraded Zumiez to Overweight from Neutral following the firm's semi-annual proprietary "Taking Stock With Teens" survey. The Zumiez brand performed better in this year's survey among upper-income teens than it had last year, noted Tamminga. The analyst raised her price target on Zumiez to $28 from $20.
INTX Intersections
$2.15

-0.1 (-4.44%)

SM SM Energy
$40.17

0.31 (0.78%)

12/01/16
STFL
12/01/16
UPGRADE
Target $51
STFL
Buy
SM Energy upgraded to Buy from Hold at Stifel
Stifel analyst Michael Scialla upgraded SM Energy to Buy with a $51 price target. The OPEC agreement to cut production resulted in Stifel raising its 2017 oil price forecast to $55/bbl from $50bbl. Scialla had been concerned about SM's plans to outspend cash flow prior to the announcement but now sees reduced risk and strong long-term growth.
10/18/16
SOCO
10/18/16
UPGRADE
Target $50
SOCO
Overweight
SM Energy upgraded to Overweight from Equalweight at Capital One
Capital One upgraded SM Energy to Overweight and raised its NAV estimates to $50 from $46 following the near doubling of its Midland Basin acreage and the acceleration of those development plans combine for $2/share of the increase. Additionally, the sale of Williston assets for $785MM was above the value he was carrying in his model by $2/share.
10/04/16
HOWW
10/04/16
UPGRADE
HOWW
Outperform
SM Energy upgraded to Outperform from Sector Perform at Scotia Howard Weil
08/30/16
GHSC
08/30/16
UPGRADE
Target $53
GHSC
Buy
SM Energy upgraded to Buy from Neutral at Seaport Global
Seaport analysts led by Mike Kelly upgraded SM Energy to Buy and raised its price target to $53 from $30 citing Permian exposure, compelling valuation, and improving leverage from the non-op Eagle Ford divestiture.
SBUX Starbucks
$58.51

0.54 (0.93%)

12/01/16
WBLR
12/01/16
NO CHANGE
WBLR
Starbucks, Amazon.com among top 2017 consumer picks at William Blair
William Blair analysts named their top consumer picks for 2017, identifying Starbucks (SBUX) as their top restaurant pick, Amazon (AMZN) as their top e-commerce pick, Sportsman's Warehouse (SPWH) as their top specialty retail pick, Urban Outfitters (URBN) as their top apparel and accessories pick, and TreeHouse (THS) as their top consumer staples pick.
11/29/16
PIPR
11/29/16
NO CHANGE
Target $64
PIPR
Overweight
Piper positive on Starbucks into December 7 analyst day
Piper Jaffray analyst Nicole Miller Regan reiterates a positive stance on Starbucks ahead of the company's analyst day on December 7. The day will offer insight into global strategies that should set up Starbucks shares for "solid outperformance" once again, Regan tells investors in a research note. She notes that the shares have underperformed the S&P 500 Index for much of the year. The analyst keeps an Overweight rating on Starbucks with a $64 price target.
11/25/16
PIPR
11/25/16
NO CHANGE
PIPR
Piper thinks blocking of Overtime Rule came too late
An Obama-appointed judge in Texas surprisingly blocked the Overtime Rule set to take effect on December 1, Piper Jaffray analysts in the Hardlines Retail & Specialty Products space tell investors in a research note. The analysts say that regardless of whether the injunction is upheld, their research suggests that the ruling comes too late for larger companies to pull back on the planned Overtime Rule change. Payroll and IT systems are likely set to adjust this coming Sunday, they point out. Piper's analysts expect the expense headwinds from the OT rule change for retailers/restaurants to remain in place. The retailers they believe that are most impacted from the rule are Dollar General (DG), Dollar Tree (DLTR), Regis (RGS) and Sally Beauty (SBH). The restaurants they believe are most impacted are Bojangles (BOJA), Starbucks (SBUX), Sonic (SONC), Noodles & Company (NDLS), Potbelly (PBPB), Del Taco (TACO) and Zoe's Kitchen (ZOES).
11/21/16
BUCK
11/21/16
INITIATION
Target $59
BUCK
Neutral
Starbucks initiated with a Neutral at Buckingham
Buckingham analyst John Zolidis initiated Starbucks with a Neutral and a $59 price target.
ATI Allegheny Technologies
$17.76

0.22 (1.25%)

08/29/16
DBAB
08/29/16
UPGRADE
Target $20
DBAB
Buy
Allegheny Technologies upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Jorge Beristain upgraded Allegheny Technologies to Buy saying leverage concerns have eased following the closure of the company's Rowley facility. Management is acting to exit low-margin stainless products, Beristain tells investors in a research note. He upped his price target for the shares to $20 from $15.
08/29/16
08/29/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. T-Mobile (TMUS) upgraded to Outperform from Market Perform at Wells Fargo, with analyst Jennifer Fritzsche saying the company's free cash flow should ramp significantly in 2017. T-Mobile should also see continued positive momentum in subscriber growth and be helped by M&A speculation post the Presidential election, said Fritzsche, who raised her price target range for the shares to $52-$54 from $48-$50. 2. KLA-Tencor (KLAC) upgraded to Outperform from Market Perform at Cowen by analyst Timothy Arcuri, who views the shares as "too interesting to ignore" regardless of the Lam Research (LRCX) deal outcome. KLA's risk/reward, even if the deal breaks, is now 3:1 to the upside, which is hard to find in semis, Arcuri tells investors in a research note. 3. Allegheny Technologies (ATI) upgraded to Buy from Hold at Deutsche Bank, with Deutsche Bank analyst Jorge Beristain saying leverage concerns have eased following the closure of the company's Rowley facility. Management is acting to exit low-margin stainless products, said Beristain. 4. CBL & Associates (CBL) upgraded to Buy from Hold at Jefferies, as analyst Omotayo Okusanya thinks "several issues" that have been an overhang on the shares are now resolved or are in the process of resolution. The company's portfolio quality is rising while its balance sheet is in better shape, Okusanya tells investors. 5. AstraZeneca upgraded to Buy from Hold at Argus. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/26/16
DBAB
10/26/16
DOWNGRADE
DBAB
Hold
Allegheny downgraded to Hold from Buy at Deutsche Bank (pre-open)
09/09/16
GHSC
09/09/16
INITIATION
Target $21
GHSC
Buy
Allegheny Technologies initiated with a Buy at Seaport Global
Seaport Global analyst Josh Sullivan initiated Allegheny Technologies with a Buy and $21 price target.
GPS Gap
$25.05

0.08 (0.32%)

11/18/16
11/18/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) downgraded to Underperform from Market Perform at BMO Capital with analyst James Fotheringham saying that the shares don't reflect the impact of its "recent cross-selling issues." 2. Gap (GPS) downgraded to Sell from Neutral at Citi with analyst Paul Lejuez citing expectations that the company's brands will continue to struggle. 3. Citi (C) downgraded to Neutral from Outperform at Macquarie with analyst David Konrad saying investors should shift exposure to names that have more leverage to capital markets and increased economic activity and away from global banks. 4. Torchmark (TMK) downgraded to Underperform from Neutral at BofA/Merrill with analyst Seth Weiss citing relative valuation. 5. First Solar (FSLR) downgraded to Sell from Neutral at UBS with analyst Julien Dumoulin-Smith saying the recently issued 2017 guidance "is not the trough in expectations." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/28/16
MSCO
11/28/16
NO CHANGE
MSCO
Softline Black Friday weekend sales mixed versus last year, says Morgan Stanley
Morgan Stanley said overall Softline Black Friday weekend sales were mixed verus last year saying L Brands (LB), lululemon (LULU), and Hollister were weekend winners and Gap (GPS), Broadridge (BR), Michael Kors (KORS), and Anthro were laggards.
11/28/16
PIPR
11/28/16
UPGRADE
Target $67
PIPR
Neutral
L Brands upgraded to Neutral from Underweight at Piper Jaffray
Piper Jaffray analyst Neely Tamminga upgraded L Brands(LB) to Neutral saying the stock at current levels is already "indicating fundamental disappointment in the near-term." The analyst keeps a $67 price target for the shares. Tamminga this morning also upgraded Gap (GPS) to Neutral.
11/28/16
PIPR
11/28/16
UPGRADE
Target $23
PIPR
Neutral
Gap upgraded to Neutral from Underweight at Piper Jaffray
Piper Jaffray analyst Neely Tamminga upgraded Gap to Neutral saying the shares, are dropping 17% since the earnings report, are appropriately reflecting concerns on fundamentals. The analyst keeps a $23 price target for the stock.

TODAY'S FREE FLY STORIES

JUNO

Juno Therapeutics

$20.43

0.53 (2.66%)

, KITE

Kite Pharma

$50.76

0.04 (0.08%)

21:25
12/03/16
12/03
21:25
12/03/16
21:25
Conference/Events
Canaccord biotech analyst to hold a dinner meeting »

In conjunction with the…

JUNO

Juno Therapeutics

$20.43

0.53 (2.66%)

KITE

Kite Pharma

$50.76

0.04 (0.08%)

BLUE

bluebird bio

$69.75

1.1 (1.60%)

NVS

Novartis

$68.17

0.42 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 03

    Dec

  • 06

    Dec

09:15
12/03/16
12/03
09:15
12/03/16
09:15
General news
Breaking General news story  »

New York Federal Reserve…

09:15
12/03/16
12/03
09:15
12/03/16
09:15
General news
Breaking General news story  »

New York Federal Reserve…

04:55
12/03/16
12/03
04:55
12/03/16
04:55
General news
Breaking General news story  »

New York Federal Reserve…

04:55
12/03/16
12/03
04:55
12/03/16
04:55
General news
Breaking General news story  »

New York Federal Reserve…

BMRN

BioMarin

$82.21

-1.12 (-1.34%)

, ESALY

Eisai

$57.91

0.59 (1.03%)

04:55
12/03/16
12/03
04:55
12/03/16
04:55
Conference/Events
American Epilepsy Society to hold annual meeting »

70th Annual Meeting of…

BMRN

BioMarin

$82.21

-1.12 (-1.34%)

ESALY

Eisai

$57.91

0.59 (1.03%)

GWPH

GW Pharmaceuticals

$112.32

3.04 (2.78%)

IART

Integra LifeSciences

$75.78

-1.07 (-1.39%)

MDT

Medtronic

$72.01

0.13 (0.18%)

MNK

Mallinckrodt

$53.61

0.51 (0.96%)

NVTA

Invitae

$6.95

0.16 (2.36%)

SAGE

SAGE Therapeutics

$49.02

-0.23 (-0.47%)

WTKWY

Wolters Kluwer

$34.08

-0.39 (-1.13%)

ZGNX

Zogenix

$13.05

0.35 (2.76%)

ZYNE

Zynerba

$13.64

0.83 (6.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

  • 12

    Dec

  • 14

    Dec

  • 28

    Jan

  • 27

    Apr

WMT

Wal-Mart

$70.88

0.21 (0.30%)

18:17
12/02/16
12/02
18:17
12/02/16
18:17
Periodicals
Wal-Mart to pay $7.5M to settle same-sex spouse benefit case, Reuters reports »

Wal-Mart said it would…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMED

Globus Medical

$21.89

0.12 (0.55%)

, TLN

Talen Energy

18:14
12/02/16
12/02
18:14
12/02/16
18:14
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

S&P Dow Jones Indices…

GMED

Globus Medical

$21.89

0.12 (0.55%)

TLN

Talen Energy

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

IM

Ingram Micro

$38.88

1.31 (3.49%)

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$111.96

0.58 (0.52%)

, ALIOF

Actelion

$206.01

15.21 (7.97%)

18:11
12/02/16
12/02
18:11
12/02/16
18:11
Periodicals
Johnson & Johnson said to raise offer for Actelion above $250, Bloomberg says »

Johnson &…

JNJ

Johnson & Johnson

$111.96

0.58 (0.52%)

ALIOF

Actelion

$206.01

15.21 (7.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$79.10

0.3 (0.38%)

18:00
12/02/16
12/02
18:00
12/02/16
18:00
Hot Stocks
Celanese to raise list, off-list selling prices for paraformaldehyde »

Celanese Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

, GMED

Globus Medical

$21.89

0.12 (0.55%)

17:56
12/02/16
12/02
17:56
12/02/16
17:56
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: HomeStreet…

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

GMED

Globus Medical

$21.89

0.12 (0.55%)

BGS

B&G Foods

$42.50

0.2 (0.47%)

ZEN

Zendesk

$21.17

0.34 (1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 09

    Jan

ZEN

Zendesk

$21.17

0.34 (1.63%)

17:53
12/02/16
12/02
17:53
12/02/16
17:53
Hot Stocks
Zendesk says SVPs Amanda Kleha and Marcus Bragg to resign »

On November 29, Amanda…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

AIXG

Aixtron

$3.97

-0.05 (-1.24%)

17:42
12/02/16
12/02
17:42
12/02/16
17:42
Periodicals
President Obama blocks China's Fujian from acquiring Aixtron, CNBC reports »

President Barack Obama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CX

CEMEX

$7.83

0.09 (1.16%)

17:31
12/02/16
12/02
17:31
12/02/16
17:31
Hot Stocks
CEMEX to divest ready-mix concrete pumping assets in Mexico »

CEMEX announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRNE

Sorrento Therapeutics

$5.15

-0.1 (-1.90%)

17:30
12/02/16
12/02
17:30
12/02/16
17:30
Syndicate
Breaking Syndicate news story on Sorrento Therapeutics »

Sorrento files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

MBRX

Moleculin Biotech

$2.63

-0.14 (-5.05%)

17:29
12/02/16
12/02
17:29
12/02/16
17:29
Syndicate
Breaking Syndicate news story on Moleculin Biotech »

Moleculin Biotech files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

NEOG

Neogen

$61.59

-1.46 (-2.32%)

17:28
12/02/16
12/02
17:28
12/02/16
17:28
Hot Stocks
Neogen acquires U.K.-based Quat-Chem, terms undisclosed »

Neogen announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RRC

Range Resources

$36.36

-0.23 (-0.63%)

17:25
12/02/16
12/02
17:25
12/02/16
17:25
Hot Stocks
Breaking Hot Stocks news story on Range Resources »

SailingStone Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EOG

EOG Resources

$103.74

-1.01 (-0.96%)

17:25
12/02/16
12/02
17:25
12/02/16
17:25
Syndicate
Breaking Syndicate news story on EOG Resources »

EOG Resources files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

, UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

17:22
12/02/16
12/02
17:22
12/02/16
17:22
Hot Stocks
Breaking Hot Stocks news story on HomeStreet, UMB Financial »

HomeStreet to replace UMB…

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

, IM

Ingram Micro

$38.88

1.31 (3.49%)

17:21
12/02/16
12/02
17:21
12/02/16
17:21
Hot Stocks
UMB Financial to replace Ingram Micro in S&P 400 as of 12/6 close »

Tianjin Tianhai…

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

IM

Ingram Micro

$38.88

1.31 (3.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMED

Globus Medical

$21.89

0.12 (0.55%)

, TLN

Talen Energy

17:20
12/02/16
12/02
17:20
12/02/16
17:20
Hot Stocks
Globus Medical to replace Talen Energy in S&P 400 as of 12/6 close »

Riverstone Holdings is…

GMED

Globus Medical

$21.89

0.12 (0.55%)

TLN

Talen Energy

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIXG

Aixtron

$3.97

-0.05 (-1.24%)

17:16
12/02/16
12/02
17:16
12/02/16
17:16
Periodicals
President Obama blocks China's takeover of Aixtron, CNBC reports »

Says the transaction…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$15.74

-0.32 (-1.99%)

17:07
12/02/16
12/02
17:07
12/02/16
17:07
Periodicals
Deutsche Bank to pay $60M settlement over gold price-fixing case, Reuters says »

Deutsche Bank will pay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

ALB

Albemarle

$84.86

-0.79 (-0.92%)

17:07
12/02/16
12/02
17:07
12/02/16
17:07
Hot Stocks
Albemarle to increase prices for select brominated products »

Albemarle announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.